PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsDynavax Technologies
Dynavax Technologies(DVAX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Heplisav bHepatitis b surface antigen2021-02-18
Heplisav-bHepatitis b vaccine (recombinant), adjuvanted2017-11-09
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Hepatitis b surface antigen
Hepatitis b virus hbsag surface protein antigen
Sodium chloride
Arm1
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use